Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of a Novel Collagenase Clostridium Histolyticum Protocol for Peyronie's Disease Among Prior Non-responders: A Randomized, Controlled, Single-Blinded Study

NCT05108558 is registered in ClinicalTrials.gov with Charitable Union for the Research and Education of Peyronie's Disease as lead sponsor.

NCT NCT05108558
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05108558 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of a Novel Collagenase Clostridium Histolyticum Protocol for Peyronie's Disease Among Prior Non-responders: A Randomized, Controlled, Single-Blinded Study
Lead sponsor
Charitable Union for the Research and Education of Peyronie's Disease
Phase
Phase 4
Overall status
Completed
Start date
September 20, 2021
Completion date
June 13, 2026
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peyronie's disease